BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,934,447 | -29.5% | 662,555 | -6.4% | 0.00% | 0.0% |
| Q2 2023 | $22,596,222 | +2.2% | 707,680 | -2.0% | 0.00% | -33.3% |
| Q1 2023 | $22,111,310 | +76156.4% | 722,135 | -2.6% | 0.00% | -25.0% |
| Q4 2022 | $28,996 | -99.9% | 741,415 | -1.8% | 0.00% | -20.0% |
| Q3 2022 | $35,975,000 | +25.8% | 755,156 | +2.2% | 0.01% | +25.0% |
| Q2 2022 | $28,600,000 | -32.8% | 738,860 | -0.5% | 0.00% | -20.0% |
| Q1 2022 | $42,555,000 | -27.2% | 742,669 | +1.3% | 0.01% | -28.6% |
| Q4 2021 | $58,421,000 | +7.2% | 733,094 | +17.0% | 0.01% | 0.0% |
| Q3 2021 | $54,514,000 | -19.4% | 626,512 | +19.2% | 0.01% | -12.5% |
| Q2 2021 | $67,668,000 | +138.5% | 525,740 | +48.3% | 0.01% | +100.0% |
| Q1 2021 | $28,372,000 | +48.2% | 354,488 | +51.2% | 0.00% | +33.3% |
| Q4 2020 | $19,141,000 | +343.7% | 234,458 | +34.3% | 0.00% | +200.0% |
| Q3 2020 | $4,314,000 | +276.4% | 174,523 | +326.4% | 0.00% | – |
| Q2 2020 | $1,146,000 | +58.5% | 40,929 | +1.8% | 0.00% | – |
| Q1 2020 | $723,000 | – | 40,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |